KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
HealthDay on MSN8h
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood AllergyOmalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...
MedPage Today on MSN23h
Rare Food Allergy Syndrome Increasingly Due to Early Egg, Peanut Introduction?SAN DIEGO -- Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than ...
In a cohort of nearly 300 pediatric patients with cystic fibrosis, food allergy was found in less than 4% of the population, ...
FARE to Debut Two New Videos at AAAAI/WAO Joint Congress, Including PSA on Early Allergen Introduction and Documentary on ...
Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut ...
HealthDay on MSN1d
Injectable Drug Resolves Dangerous Food Allergies In One-Third Of KidsMore than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Infants who were not exclusively colostrum-fed (NECF) have greater risk for food allergies at age 1, according to research presented at AAAAI/WAO.
Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to resul ...
A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback